![](/img/cover-not-exists.png)
Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low–intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol
Morel, Pierre, Munck, Jean-Nicolas, Coiffier, Bertrand, Gisselbrecht, Christian, Ranta, Dana, Bosly, Andre, Tilly, Hervé, Quesnel, Bruno, Thyss, Antoine, Mounier, Nicolas, Brière, Josette, Molina, ThiVolume:
51
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2010.504871
Date:
September, 2010
File:
PDF, 456 KB
english, 2010